CytoSorbents (CTSO) PT Raised to $18 at Maxim Group Aug 3, 2018 07:36AM
CytoSorbents (CTSO) PT Raised to $13 at Maxim Group May 14, 2018 01:23PM
CytoSorbents Achieves Record Revenue and Product Sales Growth in 2017 Mar 8, 2018 04:15PM
Cytosorbents (CTSO): Rolling Valuation To 2018 - Maxim Aug 8, 2017 08:08AM
Maxim Group Reiterates Buy Rating and $10 PT on CytoSorbents (CTSO) Following $1M Non-Dilutive Funding Awarded by DoD Apr 24, 2017 11:25AM


Apr 19, 2017 08:30AM CytoSorbents 2017 - Propelling the Company to the "Next Level"
Mar 31, 2017 08:04AM Cytosorbents (CTSO) Prices 2.22M Share Follow-On Offering at $4.50
Mar 31, 2017 08:00AM CytoSorbents Announces Pricing of Follow-On Offering
Mar 23, 2017 07:59AM Maxim Group Reiterates Buy Rating and $10 PT on Cytosorbents (CTSO) Following Dr. Carl June's Election to the Advisory Board
Mar 20, 2017 11:54AM Maxim Maintains Buy Rating and $10 PT on Cytosorbents (CTSO) Following Positive CytoSorb Cases to Treat HLH & CRS Relavance in Cancer Immunotherapy
Mar 16, 2017 11:16AM Maxim Group Reiterates Buy Rating and $110 PT on Cytosorbents (CTSO) Following Dr. Reddy Partnership
Mar 6, 2017 07:00AM CytoSorbents to Present at the Maxim Group - Haitong Securities Inaugural Healthcare Investor and Partnering Conference
Jan 23, 2017 12:19PM CytoSorbents (CTSO) PT Raised to $10 at Maxim Group
Oct 4, 2016 12:16PM CytoSorbents (CSTO) Bullish View Reiterated at Maxim Group on Commercial Launch of CytoSorb for Cardiac Surgery
Aug 9, 2016 04:15PM CytoSorbents Achieves Fourth Consecutive Quarter of Record CytoSorb® Sales
Jul 13, 2016 12:11PM CytoSorbents (CTSO) Bullish View Reiterated at Maxim Group as Two Distributors Added
Jul 6, 2016 07:27AM Cytosorbents (CTSO): Secures $10M Non-Dilutive Financing - Maxim
May 23, 2016 05:44PM Maxim Group Starts CytoSorbents (CTSO) at Buy